MDMA decreases the effects of simulated social rejection

Charles G Frye1, Margaret C Wardle1, Greg J Norman2

  • 1Department of Psychiatry and Behavioral Neurosciences, University of Chicago, USA.

Insights

3-4-Methylenedioxymethamphetamine (MDMA) reduces negative feelings associated with social rejection and decreases the perception of rejection in simulated social interactions. This suggests MDMA may enhance pro-social behavior and aid in psychotherapy.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Social Psychology

Background:

  • 3-4-Methylenedioxymethamphetamine (MDMA) is known to increase positive social feelings and reduce threat detection in faces.
  • However, its impact on subjective experiences of social acceptance and rejection remains largely undetermined.

Purpose of the Study:

  • To investigate the effects of acute MDMA dosage on subjective and autonomic responses to simulated social acceptance and rejection.
  • To explore the influence of MDMA on respiratory sinus arrhythmia (RSA) as a measure of social engagement and emotional regulation.

Main Methods:

  • Healthy adult volunteers (N=36) with prior MDMA experience participated in a double-blind, placebo-controlled study.
  • Participants received placebo, 0.75 mg/kg, or 1.5 mg/kg MDMA and engaged in a virtual social simulation (Cyberball) involving acceptance and rejection.
  • Electrocardiograms (ECGs) were recorded to calculate RSA, and participants completed mood and self-esteem questionnaires.

Main Results:

  • MDMA significantly decreased the negative impact of social rejection on mood and self-esteem.
  • Participants receiving MDMA perceived the rejection less intensely.
  • MDMA administration led to a decrease in RSA compared to placebo, consistent with its sympathomimetic effects.

Conclusions:

  • MDMA reduces subjective responses to simulated social rejection, extending findings on its effects on social threat perception.
  • These results suggest a potential cognitive mechanism for MDMA's pro-social effects and its utility as an adjunct in psychotherapy.
  • Further research in non-simulated social settings is warranted.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Deindividuation00:57

Deindividuation

Deindividuation is a form of social influence on an individual’s behavior such that the individual engages in unusual or non-normal behavior while in a group setting. Why? Because in these group settings, the individual no longer sees themselves as an individual anymore, disinhibiting their behavior and personal restraint.
22.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K